Profile of bevacizumab and its potential in the treatment of cervical cancer
نویسندگان
چکیده
Blocking angiogenesis is an effective antitumor strategy proven in many disease sites. Anti-angiogenic therapies are fulfilling the promise of improved outcomes in cervical cancer as demonstrated in several recent trials. With its overall survival improvement in metastatic or recurrent cervical cancer, a frame shift in the management of these patients has occurred. The US Food and Drug Administration approval of bevacizumab in advanced cervical cancer has led to national guidelines, including the US National Comprehensive Cancer Network guidelines for cervical cancer, including systemic regimens containing bevacizumab as first line combination therapy. Future trials will build on this anti-angiogenesis backbone via targeting additional novel pathways and potentially leading to further improved outcomes in cervical cancer.
منابع مشابه
Genistein Induces a Protective Immunomodulatory Effect in a Mouse Model of Cervical Cancer
Background: Genistein (GEN), a naturally occurring flavonoid present in soy bean, has attracted scientific interest for its possible benefits in cancer. Objective: The potential immunomodulatory effects of genistein on the immune system and against TC-1 tumor cell line were evaluated in adult female C57BL/6 mice. Methods: Mice were treated with GEN 10 days before to 10 days after the tumor indu...
متن کاملRelationship between Quality of Life and Social Support in Women Treated for Cervical Cancer
Background and Objectives: Cervical cancer is one of the most common cancers in developing countries. This disease and its treatment influence various aspects of quality of life. The purpose of this study was to assess the relationship between the quality of life and social support among cervical cancer survivors. Material and Methods: In this study 65 women treated for cervica...
متن کاملClinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence
The addition of bevacizumab to established therapies for metastatic and locally advanced cervical cancer is an area of evolving research and a potential strategy toward improving historically suboptimal outcomes for women with advanced disease. Bevacizumab, when added to first-line chemotherapy, has now been shown to improve overall survival among women with metastatic cervical cancer, and rece...
متن کاملEvaluation of the effect of methanolic extract of pomegranate peel on cytotoxicity induction and PDGF gene expression in cervical cancer (Hela cell line)
Background & Aim: Extract of pomegranate peel is a potential bioactive substance to combat cancer due to its rich cytotoxic components including polyphenols. This study aimed to identify phytochemical ingredients of pomegranate peel extract and assessed the level of their cytotoxicity on a cervical cancer cell line. In addition, the effect of this extract on expression of a key gene in the proc...
متن کاملConstruction a DNA Vaccine Containing Human Papillomavirus Type 16 Early Genes as a Potential Vaccine for Cervical Cancer Prevention and Therapy
Background and Objectives: Some of the human papillomaviruses (HPVs) can infect genital tracts and are sometimes associated with anogenital tract cancers. HPVs induced cervical cancers through the expression of E6 and E7 genes by inactivating the tumor suppressor proteins. In this study, E6 and E7 genes were chosen in order to construct an expression vector which is able to express ...
متن کامل